Print

Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Says FDA To Take More Time To Review Label Wording for Acthar  
9/9/2010 7:17:14 AM

Sept 8 (Reuters) - Questcor Pharmaceuticals Inc (QCOR.O) said U.S. health regulators extended, for the second time, review of the company's Acthar gel to treat seizures in infants.
//-->